about
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesisChemical metabolic inhibitors for the treatment of blood-borne cancers1,25-dihydroxyvitamin D3 enhances the apoptotic activity of MDM2 antagonist nutlin-3a in acute myeloid leukemia cells expressing wild-type p53.Tumor suppressor p53 status does not determine the differentiation-associated G₁ cell cycle arrest induced in leukemia cells by 1,25-dihydroxyvitamin D₃ and antioxidants.The molecular genetics of hematologic malignanciesClinical significance of P53 and Bcl-2 in acute myeloid leukemia patients of Eastern India.Immunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infectionUnilateral conjunctival AL kappa amyloidosis with trace evidence of systemic amyloidosis.Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia modelsPrognostic implications of cyclin B1, p34cdc2, p27(Kip1) and p53 expression in gastric cancerBiologic features and treatment outcome of secondary acute lymphoblastic leukemia--a review of 101 cases.Mutational analysis of TP53, PTEN, PIK3CA and CTNNB1/beta-catenin genes in human herpesvirus 8-associated primary effusion lymphomaAn MDM2 antagonist (MI-319) restores p53 functions and increases the life span of orally treated follicular lymphoma bearing animals.The genomic landscape of hypodiploid acute lymphoblastic leukemia.Secondary Acute Lymphoblastic Leukemia after Hodgkin's Lymphoma or a Coincidental Association of Two Hematological Malignancies?The p53 tumor suppressor protein regulates hematopoietic stem cell fate.Reversion of apoptotic resistance of TP53-mutated Burkitt lymphoma B-cells to spindle poisons by exogenous activation of JNK and p38 MAP kinases.Apoptosis in haematological malignanciesMutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells.p53 gene mutations in multiple myeloma.Molecular analysis of tumor suppressor genes, Rb, p53, p16INK4A, p15INK4B and p14ARF in natural killer cell neoplasms.p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization.A rare case of Philadelphia chromosome-positive chronic myelogenous leukemia with inversion in chromosome 9 and t(10;17).A novel dic (17;18) (p13.1;q11.2) with loss of TP53 and BCR/ABL rearrangement in an Imatinib resistant chronic myeloid leukemia.INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene.Protein expression of cell cycle regulator, p27Kip1, correlates with histopathological grade of non-Hodgkin's lymphoma.
P2860
Q24654905-12921832-9348-47B0-B79D-0356D9D0C135Q28822335-C3844E9E-A915-46A6-920D-7B934C5C39B1Q33843653-786A7A8D-EA76-4804-A498-8619BA3B4144Q34581838-29CA48A3-C716-4B68-A455-FE5BDC6BC985Q35224361-12AA2C2B-3741-4D64-B61F-0909D103B1D6Q35720084-1216A748-5975-449C-B972-A609AB6864BDQ35782275-DA2F5A54-83B6-464D-A672-9D3D4B8C79FCQ36738695-708A37BD-86F8-48BC-9AD4-22D74B0CD5CAQ37045295-4837693F-BA96-4AA2-8754-6819AD568170Q37065279-60CB18F3-6EF7-4481-8E08-DE69392CFA37Q37158199-A77795F3-2E51-4BB2-82C9-374FF11866A4Q37284423-0C1C8DA2-2FE4-4819-A835-859144EEEAA9Q37477829-91FBAB2C-C452-46FD-9AB4-18F9A8FA98F4Q37574743-518D5FAA-C4DD-4F58-859F-3CB60FDB2F19Q37670277-56233632-C209-4F2B-96E7-7C6968550E28Q37887629-10B09AB3-AA8C-4F75-BCE4-A5C35261B8AEQ38999750-33858D33-FE1A-4F02-A4AC-2901BB25FB6DQ39568120-88E64F39-F85B-4FE8-A8ED-AB44C2F267D2Q39882046-56F756BD-B755-492C-B678-E31F20BC7987Q40727007-3AC0BBF5-A781-466E-99FB-CC7818510159Q40772738-B9DB34C1-630C-4374-9BAF-849E1641278CQ40979144-5BC542D9-B8F6-4932-A428-7842FEC1042BQ42089789-01027F4B-7756-4F15-985B-5E040BED7741Q42533789-C76584B8-4649-4750-A75B-71B53E0711FEQ42791337-7A0BA4F2-070B-4812-8BA0-6F49A94F0BF5Q44453229-E07CC755-6C94-4739-AC7A-6F24E70B38A1
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
p53 in hematologic malignancies.
@en
type
label
p53 in hematologic malignancies.
@en
prefLabel
p53 in hematologic malignancies.
@en
P2093
P1433
P1476
p53 in hematologic malignancies
@en
P2093
P304
P407
P577
1994-10-01T00:00:00Z